Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis

被引:21
作者
Fukuta, D
Miyagawa, S
Yamada, M
Matsunami, K
Kurihara, T
Shirasu, A
Hattori, H
Shirakura, R
机构
[1] Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Regenerat Med, Suita, Osaka 5650871, Japan
[2] Anim Engn Res Inst, Ibaraki, Japan
[3] Nipro Corp, Res & Dev Lab, Osaka, Japan
关键词
C1-INH; complement; xenograft;
D O I
10.1034/j.1399-3089.2003.01120.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of the present study was to assess the effect of various forms of the surface-bound form of the C1 esterase inhibitor (C1-INH-PI) and decay accelerating factor (DAF) on xenogenic cells. cDNAs of various deletion mutants of the C1-INH-PI, such as delta-1-99 amino acid (AA), delta-108-183AA loop, delta-whole loop, delta-exon5, delta-exon6 + 7, and delta-exon5 + 6 + 7, and that of DAF, the delta-short consensus repeat (SCR) 1-DAF were established. While all deletion mutants of C1-INH-PI except the delta-1-99AA were expressed in the cytoplasm but not on the cell surface, the delta-1-99AA was clearly expressed on the xenogeneic cell surface. Amelioration of complement-mediated xenogeneic cell lysis by delta-1-99AA was next tested, and compared with delta-SCR1 DAF. Both molecules blocked human complement-mediated cell lysis by approximately 57 to 90 and 93 to 98%, respectively, in Chinese hamster ovarian tumor (CHO) cells and pig endothelial cells (PECs). The CHO cell transfectants were incubated with 20% normal human serum, and the amounts of C4 and C3 deposition on the cell surface were analysed by flow cytometry. The DAF transfectant showed a large amount of C4-deposition and much less C3-deposition than the controls (approximately 85% suppression), whereas the delta-1-99AA showed approximately a 40% suppression in both C4- and C3-deposition. Consequently, both the delta-1-99AA C1-INH-PI and delta-SCR1 DAF molecules are quite effective in down-regulating the xenogeneic cell lysis, but accomplished this in different manners.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 50 条
[41]   An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor [J].
Zhang, Haimou ;
Li, Jinan ;
Barrington, Robert A. ;
Liang, Gang ;
Qin, Gangjian ;
Liu, Dong-Xu .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 359 (02) :285-291
[42]   Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury [J].
Fu, Jinrong ;
Lin, Guosheng ;
Wu, Zhiwei ;
Ceng, Bin ;
Wu, Yanxia ;
Liang, Gong ;
Qin, Gangjian ;
Li, Jinan ;
Chiu, Isaac ;
Liu, Dongxu .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (02) :504-512
[43]   Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity [J].
Fu, Jinrong ;
Lin, Guosheng ;
Zeng, Bin ;
Wu, Zhiwei ;
Wu, Yanxia ;
Chu, Honggang ;
Qin, Gangjian ;
Liang, Gong ;
Li, Jinan ;
Gan, Xiang ;
Yu, Xiaolan ;
Li, Chunhua ;
Liu, Dongxu .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (01) :162-168
[44]   C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study [J].
Viglietti, D. ;
Gosset, C. ;
Loupy, A. ;
Deville, L. ;
Verine, J. ;
Zeevi, A. ;
Glotz, D. ;
Lefaucheur, C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (05) :1596-1603
[45]   Effects of C1 inhibitor on endothelial cell activation in a rat hind limb ischemia-reperfusion injury model [J].
Zhang, Shengye ;
Shaw-Boden, Jane ;
Banz, Yara ;
Bongoni, Anjan K. ;
Taddeo, Adriano ;
Spirig, Rolf ;
Nolte, Marc W. ;
Cowan, Peter J. ;
Rieben, Robert .
JOURNAL OF VASCULAR SURGERY, 2018, 68 (06) :209S-+
[46]   Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates [J].
Tassani, P ;
Kunkel, R ;
Richter, JA ;
Oechsler, H ;
Lorenz, HP ;
Braun, SL ;
Eising, GP ;
Haas, F ;
Paek, SU ;
Bauernschmitt, R ;
Jochum, M ;
Lange, R .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (04) :469-473
[47]   Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice [J].
Bhutta, Maimoona S. ;
Sausen, Daniel G. ;
Reed, Kirstin M. ;
Gallo, Elisa S. ;
Hair, Pamela S. ;
Lassiter, Brittany P. ;
Krishna, Neel K. ;
Cunnion, Kenji M. ;
Borenstein, Ronen .
VIRUSES-BASEL, 2021, 13 (08)
[48]   Antithrombin III, but not C1 esterase inhibitor reduces inflammatory response in lipopolysaccharide-stimulated human monocytes in an ex-vivo whole blood setting [J].
Kellner, Patrick ;
Nestler, Frank ;
Leimert, Anja ;
Bucher, Michael ;
Czeslick, Elke ;
Sablotzki, Armin ;
Raspe, Christoph .
CYTOKINE, 2014, 70 (02) :173-178
[49]   Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial [J].
Riedl, Marc A. ;
Grivcheva-Panovska, Vesna ;
Moldovan, Dumitru ;
Baker, James ;
Yang, William H. ;
Giannetti, Bruno M. ;
Reshef, Avner ;
Andrejevic, Sladjana ;
Lockey, Richard F. ;
Hakl, Roman ;
Kivity, Shmuel ;
Harper, Joseph R. ;
Relan, Anurag ;
Cicardi, Marco .
LANCET, 2017, 390 (10102) :1595-1602
[50]   Plasma-Derived Human C1-Esterase Inhibitor Does Not Prevent Mechanical Ventilation-Induced Pulmonary Complement Activation in a Rat Model of Streptococcus pneumoniae Pneumonia [J].
de Beer, F. M. ;
Aslami, H. ;
Hoeksma, J. ;
van Mierlo, G. ;
Wouters, D. ;
Zeerleder, S. ;
Roelofs, J. J. T. H. ;
Juffermans, N. P. ;
Schultz, M. J. ;
Lagrand, W. K. .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (02) :795-803